Once completed, antibody-drug conjugate developer LegoChem Biosciences will become a part of Orion Group’s corporate family but will keep its current management and framework.
Once completed, antibody-drug conjugate developer LegoChem Biosciences will become a part of Orion Group’s corporate family but will keep its current management and framework.